GURUFOCUS.COM » STOCK LIST » USA » NAS » Neuronetics Inc (NAS:STIM) » Definitions » EV-to-EBITDA
Switch to:

Neuronetics EV-to-EBITDA

: -2.32 (As of Today)
View and export this data going back to 2018. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Neuronetics's enterprise value is $81.71 Mil. Neuronetics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $-35.15 Mil. Therefore, Neuronetics's EV-to-EBITDA for today is -2.32.

The historical rank and industry rank for Neuronetics's EV-to-EBITDA or its related term are showing as below:

STIM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -29.74   Med: -4.05   Max: 0.01
Current: -2.45

During the past 6 years, the highest EV-to-EBITDA of Neuronetics was 0.01. The lowest was -29.74. And the median was -4.05.

STIM's EV-to-EBITDA is ranked worse than
100% of 137 companies
in the Medical Diagnostics & Research industry
Industry Median: 13.37 vs STIM: -2.45

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2022-08-11), Neuronetics's stock price is $4.40. Neuronetics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $-1.400. Therefore, Neuronetics's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Neuronetics EV-to-EBITDA Historical Data

The historical data trend for Neuronetics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuronetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBITDA
Premium Member Only - -12.00 -1.52 -7.72 -2.07

Neuronetics Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.85 -4.19 -2.07 -1.16 -1.50

Competitive Comparison

For the Diagnostics & Research subindustry, Neuronetics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Neuronetics EV-to-EBITDA Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Neuronetics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Neuronetics's EV-to-EBITDA falls into.



Neuronetics EV-to-EBITDA Calculation

Neuronetics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=81.710/-35.147
=-2.32

Neuronetics's current Enterprise Value is $81.71 Mil.
Neuronetics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-35.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuronetics  (NAS:STIM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Neuronetics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.40/-1.400
=At Loss

Neuronetics's share price for today is $4.40.
Neuronetics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.400.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Neuronetics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Neuronetics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuronetics Business Description

Neuronetics logo
Traded in Other Exchanges
Address
3222 Phoenixville Pike, Malvern, PA, USA, 19355
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Executives
Cannell Capital Llc 10 percent owner 245 MERIWETHER CIRCLE ALTA WY 83414
Rosengarten Megan director C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355
Cascella Robert director C/O HOLOGIC, INC. BEDFORD MA 01730
Shook Bruce Joseph director 162 CRICKET AVE ARDMORE PA 19003
Jaeger Wilfred E director C/O THREE ARCH PARTNERS 3200 ALPINE RD PORTOLA VALLEY CA 94028
Bakewell John K director C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NO. BILLERICA MA 01862
Conley Sheryl L director C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355
Muir Glenn P director C/O HOLOGIC, INC. BEDFORD MA 01730
Sullivan Keith J director, officer: President and CEO C/O RELIANT TECHNOLOGIES, INC. 464 ELLIS STREET MOUNTAIN VIEW CA 94043
Macan William Andrew officer: Sr. VP, GC, CCO and Secretary 24275 KATY FREEWAY, SUITE 600 KATY TX 77494
Harper Gregory officer: VP of Prod. Dev. & Operations C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355
Furlong Stephen officer: CFO C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355
Tropsha Yelena officer: VP of Commercial Access C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355
Farley Brian E director 2200 ZANKER ROAD SUITE F SAN JOSE CA 95131
Guthrie Daniel officer: Chief Commercial Officer C/O NEURONETICS, INC 322 PHOENIXVILLE PIKE MALVERN PA 19355

Neuronetics Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)